124 related articles for article (PubMed ID: 16459257)
1. Reduced 125I-meta-iodobenzylguanidine uptake and norepinephrine transporter density in the hearts of mice with MPTP-induced parkinsonism.
Fukumitsu N; Suzuki M; Fukuda T; Kiyono Y; Kajiyama S; Saji H
Nucl Med Biol; 2006 Jan; 33(1):37-42. PubMed ID: 16459257
[TBL] [Abstract][Full Text] [Related]
2. Multipoint analysis of reduced (125)I-meta-iodobenzylguanidine uptake and norepinephrine turnover in the hearts of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine-induced parkinsonism.
Fukumitsu N; Suzuki M; Fukuda T; Kiyono Y
Nucl Med Biol; 2009 Aug; 36(6):623-9. PubMed ID: 19647168
[TBL] [Abstract][Full Text] [Related]
3. Significant reduction of 125 I-meta-iodobenzylguanidine accumulation directly caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine, a toxic agent for inducing experimental Parkinson's disease.
Takatsu H; Wada H; Maekawa N; Takemura M; Saito K; Fujiwara H
Nucl Med Commun; 2002 Feb; 23(2):161-6. PubMed ID: 11891470
[TBL] [Abstract][Full Text] [Related]
4. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
[TBL] [Abstract][Full Text] [Related]
5. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats.
Kiyono Y; Iida Y; Kawashima H; Ogawa M; Tamaki N; Nishimura H; Saji H
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):999-1005. PubMed ID: 12173012
[TBL] [Abstract][Full Text] [Related]
6. Dependence of cardiac 11C-meta-hydroxyephedrine retention on norepinephrine transporter density.
Raffel DM; Chen W; Sherman PS; Gildersleeve DL; Jung YW
J Nucl Med; 2006 Sep; 47(9):1490-6. PubMed ID: 16954558
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m labeled 1-(4-fluorobenzyl)-4-(2-mercapto-2-methyl-4-azapentyl)-4-(2-mercapto-2-methylpropylamino)-piperidine and iodine-123 metaiodobenzylguanidine for studying cardiac adrenergic function: a comparison of the uptake characteristics in vascular smooth muscle cells and neonatal cardiac myocytes, and an investigation in rats.
Samnick S; Scheuer C; Münks S; El-Gibaly AM; Menger MD; Kirsch CM
Nucl Med Biol; 2004 May; 31(4):511-22. PubMed ID: 15093822
[TBL] [Abstract][Full Text] [Related]
8. No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity.
Verberne HJ; de Bruin K; Habraken JB; Somsen GA; Eersels JL; Moet F; Booij J; van Eck-Smit BL
Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):483-90. PubMed ID: 16425032
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-labeled MIBG derivatives: novel 99mTc complexes as myocardial imaging agents for sympathetic neurons.
Zhuang ZP; Kung MP; Mu M; Hou C; Kung HF
Bioconjug Chem; 1999; 10(2):159-68. PubMed ID: 10077463
[TBL] [Abstract][Full Text] [Related]
10. Age-related changes of myocardial norepinephrine transporter density in rats: implications for differential cardiac accumulation of MIBG in aging.
Kiyono Y; Kanegawa N; Kawashima H; Iida Y; Kinoshita T; Tamaki N; Nishimura H; Ogawa M; Saji H
Nucl Med Biol; 2002 Aug; 29(6):679-84. PubMed ID: 12234593
[TBL] [Abstract][Full Text] [Related]
11. Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG.
Kiyono Y; Kajiyama S; Fujiwara H; Kanegawa N; Saji H
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):438-42. PubMed ID: 15821963
[TBL] [Abstract][Full Text] [Related]
12. Regional alterations of myocardial norepinephrine transporter density in streptozotocin-induced diabetic rats: implications for heterogeneous cardiac accumulation of MIBG in diabetes.
Kiyono Y; Iida Y; Kawashima H; Tamaki N; Nishimura H; Saji H
Eur J Nucl Med; 2001 Jul; 28(7):894-9. PubMed ID: 11504086
[TBL] [Abstract][Full Text] [Related]
13. Myocardial nerve fibers are preserved in MPTP-treated mice, despite cardiac sympathetic dysfunction.
Amino T; Uchihara T; Tsunekawa H; Takahata K; Shimazu S; Mizusawa H; Orimo S
Neurosci Res; 2008 Mar; 60(3):314-8. PubMed ID: 18242750
[TBL] [Abstract][Full Text] [Related]
14. Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.
Zhao Y; Zhong X; Ou X; Cai H; Wu X; Huang R
Front Med; 2017 Mar; 11(1):120-128. PubMed ID: 28213878
[TBL] [Abstract][Full Text] [Related]
15. Influence of the polyol pathway on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG.
Kiyono Y; Kajiyama S; Fujiwara H; Kanegawa N; Saji H
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):993-7. PubMed ID: 16261676
[TBL] [Abstract][Full Text] [Related]
16. Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism.
Kim JS; Lee PH; Lee KS; Park JW; Kim YI; Chung YA; Kim SH; Kim SH; Kim J; Choi YY; Kim HT
Mov Disord; 2006 Nov; 21(11):1990-4. PubMed ID: 16991157
[TBL] [Abstract][Full Text] [Related]
17. A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.
Vaidyanathan G; Welsh PC; Vitorello KC; Snyder S; Friedman HS; Zalutsky MR
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1362-70. PubMed ID: 15205923
[TBL] [Abstract][Full Text] [Related]
18. Spatial Inhomogeneity of Cardiac Norepinephrine Transport Protein and Meta-[
Kusmic C; Giorgetti A; Barsanti C; Burchielli S; Petroni D; Kusch A; Genovesi D; Menichetti L; Marzullo P
Mol Imaging Biol; 2019 Jun; 21(3):482-490. PubMed ID: 30187232
[TBL] [Abstract][Full Text] [Related]
19. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
Altmann A; Kissel M; Zitzmann S; Kübler W; Mahmut M; Peschke P; Haberkorn U
J Nucl Med; 2003 Jun; 44(6):973-80. PubMed ID: 12791828
[TBL] [Abstract][Full Text] [Related]
20. Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.
More SS; Itsara M; Yang X; Geier EG; Tadano MK; Seo Y; Vanbrocklin HF; Weiss WA; Mueller S; Haas-Kogan DA; Dubois SG; Matthay KK; Giacomini KM
Clin Cancer Res; 2011 Apr; 17(8):2339-49. PubMed ID: 21421857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]